SciClone Pharmaceuticals (Holdings) Limited
HKEX:6600.HK
Overview | Financials
Company Name | SciClone Pharmaceuticals (Holdings) Limited |
Symbol | 6600.HK |
Currency | HKD |
Price | 18.72 |
Market Cap | 11,799,153,120 |
Dividend Yield | 2.32% |
52-week-range | 8.75 - 18.72 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Hong Zhao |
Website | https://www.sciclone.com |
An error occurred while fetching data.
About SciClone Pharmaceuticals (Holdings) Limited
SciClone Pharmaceuticals (Holdings) Limited, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products in the therapeutic areas of oncology and severe infection in Mainland China and internationally. The company's proprietary product is Zadaxin, which is used for the treatment of hepatitis B and hepatitis C viruses, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD